跳至主要内容
临床试验/ACTRN12609001007224
ACTRN12609001007224尚未招募未知

A study of kinins involved in the inflammation and pain associated with osteoarthritis of the knee

Royal Perth Hospital0 个研究点目标入组 30 人开始时间: 2009年11月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • *primary knee osteoarthritis (OA), which has been diagnosed based on clinical and radiographic criteria, according to the American College of Rheumatology(knee pain,either age > 50 or morning stiffness < 30 mins or crepitus, osteophytes)
  • *With radiographic evidence of OA for the studied knee based on retrospective bilateral radiography (within last 12 months): Anterior-posterior view in extension and weight bearing position and sky-line view”; radiographic changes defined by Kellgren-Lawrence score (I to V)
  • *Moderately severe symptoms (> or =40/100 on pain Visual Analogue Scale)
  • *Aged more than 18 years
  • *Able to provide written informed consent

排除标准

  • *Contraindication or unwillingness to undergo an Ultrasound scan
  • *Contraindication or unwillingness to undergo arthrocentesis(including an International normalised ratio greater than 2.0 in subjects on warfarin, or patients on therapeutic dose heparin/ Low Molecular Weight heparin)
  • *Diagnosis of septic arthritis, inflammatory joint disease, gout, recurrent episodes of pseudogout, Paget’s disease, articular fracture, ochronosis, acromegaly, haemochromatosis, Wilson’s disease, primary osteochondrosis
  • *With secondary OA, as defined by The Group for the Respect of Ethics and Excellence in Science: septic arthritis, inflammatory joint disease, gout, recurrent episodes of pseudogout, Paget’s disease, articular fracture, ochronosis, acromegaly, haemochromatosis, Wilson’s disease, primary osteochondrosis
  • *With injury to the study knee within 6 months of the study start
  • *With a knee joint replacement (partial or total); osteotomy of the studied joint; with arthroscopy of the studied joint made within 1 year of the study start
  • *With an intra articular injection of steroids made within 4 weeks and/or intra articular injection of radionuclide made with 3 months prior to study entry

研究者

相似试验